StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
34
This year
1
Publishing Date
2024 - 03 - 25
1
2023 - 12 - 11
2
2023 - 11 - 23
1
2023 - 09 - 14
1
2023 - 07 - 20
2
2023 - 06 - 27
1
2023 - 05 - 01
1
2023 - 04 - 03
1
2023 - 03 - 08
1
2022 - 05 - 17
1
2022 - 05 - 10
1
2022 - 04 - 21
1
2022 - 04 - 14
1
2022 - 01 - 11
1
2021 - 12 - 21
1
2021 - 11 - 22
1
2021 - 11 - 10
1
2021 - 08 - 25
1
2021 - 07 - 06
1
2021 - 06 - 17
2
2021 - 06 - 02
1
2021 - 05 - 24
1
2021 - 05 - 07
1
2021 - 05 - 03
1
2021 - 04 - 19
1
2021 - 04 - 12
1
2021 - 04 - 06
1
2021 - 03 - 16
1
2021 - 01 - 12
1
2020 - 07 - 22
1
2020 - 07 - 08
1
Sector
Health technology
34
Manufacturing
1
Technology services
1
Tags
Acquisition
87
Alliances
89
America
64
Antibody
65
Approval
97
Biopharma
103
Biotech
87
Biotechnology
120
Business
80
Cancer
215
Children
68
Clinical-trials-phase-ii
51
Clinical-trials-phase-iii
80
Collaboration
102
Companies
59
Conference
58
Covid
128
Covid-19
111
Diabetes
60
Disease
179
Drug
240
Dupixent
118
Earnings
96
Europe
92
Events
61
Fda
236
Financial
163
Financial results
72
Genetown
73
Global
356
Growing
56
Growth
325
Health
71
Insulin
54
Iot
56
Market
719
Money
70
N/a
2816
News
123
People
224
Pharm-country
54
Pharma
191
Pharmaceutical
143
Positive
103
Potential
67
Regulatory
58
Report
312
Research
265
Results
366
Sanofi
199
Spac
62
Study
86
Technology
68
Therapeutics
342
Therapy
113
Treatment
277
Trial
165
Update
91
Vaccine
258
Year
61
Entities
Astrazeneca plc
1
Baidu, inc.
1
Biontech se
2
First wave biopharma, inc.
1
Global blood therapeutics, inc.
1
Innate pharma s.a.
1
Innate pharma sa
1
Kazia therapeutics limited
1
Ligand pharmaceuticals incorporated
2
Opko health, inc.
1
Pfizer, inc.
2
Rallybio corp
1
Regeneron pharmaceuticals, inc.
3
Sanofi
34
Teva pharmaceutical industries ltd
1
Symbols
ABBV
5
ABEO
7
ADCT
6
ADEA
14
ADXS
6
AGEN
6
ALPMF
17
ALPMY
17
ALVO
8
AQST
5
AZN
16
BGNE
10
BIIB
16
BLIN
5
BMY
12
BNTX
6
CEVA
5
CHRS
6
CPRX
5
CRCW
5
DTIL
5
DYAI
6
EXEL
9
FBIO
9
GILD
13
GMAB
14
GNMSF
11
GSK
10
HALO
6
IDCC
8
IGT
5
IMGN
6
INCY
5
JAGX
6
JAZZ
5
JNJ
45
KMDA
9
LCTX
5
LLY
26
MDT
7
MESO
5
MRK
9
NVO
5
NVS
10
NVSEF
6
OTLK
5
PFE
19
PNT
5
QTRHF
6
SGEN
10
SNY
34
SNYNF
19
SRNE
14
TAK
13
TEVJF
11
TGTX
6
TMDI
6
TNXP
7
VYGR
6
XNCR
6
Exchanges
Nasdaq
34
Nyse
2
Crawled Date
2024 - 03 - 25
1
2023 - 12 - 12
1
2023 - 12 - 11
1
2023 - 11 - 23
1
2023 - 09 - 14
1
2023 - 07 - 20
2
2023 - 06 - 27
1
2023 - 05 - 01
1
2023 - 04 - 03
1
2023 - 03 - 08
1
2022 - 05 - 17
1
2022 - 05 - 10
1
2022 - 04 - 21
1
2022 - 04 - 14
1
2022 - 01 - 12
1
2021 - 12 - 21
1
2021 - 11 - 22
1
2021 - 11 - 10
1
2021 - 08 - 25
1
2021 - 07 - 06
1
2021 - 06 - 17
2
2021 - 06 - 02
1
2021 - 05 - 24
1
2021 - 05 - 07
1
2021 - 05 - 03
1
2021 - 04 - 19
1
2021 - 04 - 12
1
2021 - 04 - 06
1
2021 - 03 - 16
1
2021 - 01 - 12
1
2020 - 12 - 01
2
Crawled Time
00:00
1
01:00
1
07:00
4
08:00
1
10:00
2
11:00
5
12:00
5
12:15
1
13:00
3
13:15
1
13:30
1
15:00
1
17:00
2
18:00
2
21:00
1
22:00
1
22:14
2
Source
www.biospace.com
14
www.globenewswire.com
12
www.prnewswire.com
8
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
License
symbols :
SNY
save search
Regeneron Provides Update on Biologics License Application for Odronextamab
Published:
2024-03-25
(Crawled : 11:00)
- globenewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-1.09%
|
O:
-100.0%
H:
NaN%
C:
Infinity%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-5.33%
|
O:
0.42%
H:
0.0%
C:
0.0%
REGN
|
$896.27
0.26%
0.25%
500K
|
Health Technology
|
-6.83%
|
O:
-1.37%
H:
1.15%
C:
0.74%
license
update
application
Maze Therapeutics Announces FTC Action Seeking to Block Collaboration and License Agreement with Sanofi Regarding MZE001, a Potential Oral Substrate Reduction Therapy for Pompe Disease
Published:
2023-12-11
(Crawled : 00:00)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-0.54%
|
O:
0.5%
H:
1.67%
C:
0.1%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-1.51%
|
O:
2.15%
H:
0.0%
C:
0.0%
mze001
disease
license
collaboration
therapeutics
potential
agreement
therapy
sanofi
Press Release: Statement on FTC challenge to proposed license agreement with Maze Therapeutics
Published:
2023-12-11
(Crawled : 21:00)
- globenewswire.com
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-3.59%
|
O:
0.43%
H:
0.0%
C:
0.0%
license
therapeutics
agreement
Simcere and Connect Enter into an exclusive license and collaboration agreement for the innovative autoimmune drug Rademikibart
Published:
2023-11-23
(Crawled : 08:00)
- prnewswire.com
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
Email alert
Add to watchlist
drug
license
collaboration
agreement
First Wave BioPharma Announces Exclusive Global License Agreement for Capeserod from Sanofi
Published:
2023-09-14
(Crawled : 10:00)
- globenewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-13.74%
|
O:
2.14%
H:
0.0%
C:
-1.3%
FWBI
|
$2.59
-8.8%
-9.65%
83K
|
Manufacturing
|
-67.36%
|
O:
109.38%
H:
21.84%
C:
-44.24%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-16.08%
|
O:
0.26%
H:
0.74%
C:
0.33%
license
biopharma
global
agreement
sanofi
Idorsia sells its Asia Pacific (ex-China) operations – including select license rights to products – to Sosei Heptares for a total consideration of CHF 400 million
Published:
2023-07-20
(Crawled : 07:00)
- globenewswire.com
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-15.61%
|
O:
1.2%
H:
0.7%
C:
0.27%
license
asia
total
Sosei Heptares - Investor and Press Conference on Today’s Announcement Regarding the Acquisition and License Transaction with Idorsia
Published:
2023-07-20
(Crawled : 07:00)
- globenewswire.com
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-15.61%
|
O:
1.2%
H:
0.7%
C:
0.27%
announcement
conference
license
acquisition
FDA Issues Complete Response Letter (CRL) for Aflibercept 8 mg Biologics License Application Solely Due to an Ongoing Review of Inspection Findings at a Third-party Filler
Published:
2023-06-27
(Crawled : 18:00)
- globenewswire.com
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-15.05%
|
O:
0.75%
H:
0.0%
C:
0.0%
REGN
|
$896.27
0.26%
0.25%
500K
|
Health Technology
|
25.85%
|
O:
-1.1%
H:
0.26%
C:
-1.16%
fda
license
review
ongoing
application
response
Maze Therapeutics Announces Exclusive Worldwide License Agreement with Sanofi for MZE001, an Oral Substrate Reduction Therapy for the Treatment of Pompe Disease
Published:
2023-05-01
(Crawled : 12:00)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-13.33%
|
O:
4.08%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-16.59%
|
O:
-1.21%
H:
0.0%
C:
0.0%
mze001
disease
license
treatment
therapeutics
agreement
therapy
sanofi
Innate Pharma Announces Exclusive License of Antibodies to Takeda for Celiac Disease Research Program
Published:
2023-04-03
(Crawled : 07:00)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-14.95%
|
O:
0.23%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-16.4%
|
O:
-0.05%
H:
0.0%
C:
0.0%
IPHA
|
$2.48
5.53%
5.24%
9.4K
|
Health Technology
|
-17.54%
|
O:
14.39%
H:
3.99%
C:
-3.37%
pharma
disease
license
research
program
OPKO Health’s ModeX Therapeutics Enters into Exclusive Worldwide License and Collaboration Agreement with Merck to Develop Epstein-Barr Virus Vaccine Candidate
Published:
2023-03-08
(Crawled : 13:00)
- globenewswire.com
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-5.27%
|
O:
-0.93%
H:
0.0%
C:
0.0%
OPK
|
$1.23
0.0%
2.7M
|
Health Technology
|
16.04%
|
O:
20.75%
H:
3.13%
C:
-11.72%
candidate
collaboration
vaccine
license
virus
therapeutics
agreement
LifeArc co-founded company RQ Bio signs licensing agreement with AstraZeneca worth up to $157m plus royalties for monoclonal antibodies against SARS-CoV-2
Published:
2022-05-17
(Crawled : 07:00)
- prnewswire.com
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
6.89%
|
O:
4.22%
H:
0.0%
C:
-2.05%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-12.51%
|
O:
1.5%
H:
0.64%
C:
0.19%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
7.55%
|
O:
3.17%
H:
0.0%
C:
0.0%
royalties
sars-cov-2
license
antibody
Rallybio Announces In-Licensing of Potential First-In-Class Preclinical Antibody Candidate from Sanofi
Published:
2022-05-10
(Crawled : 12:00)
- biospace.com/
RLYB
|
News
|
$1.75
4.79%
4.57%
310K
|
|
-84.47%
|
O:
-7.81%
H:
9.95%
C:
5.32%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-10.76%
|
O:
1.06%
H:
0.0%
C:
0.0%
preclinical
antibody
potential
sanofi
license
pre-clinical
Terran Biosciences announces licensing deal with Sanofi for two late-stage CNS pipeline assets
Published:
2022-04-21
(Crawled : 13:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-17.17%
|
O:
0.07%
H:
0.08%
C:
-1.12%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-17.28%
|
O:
2.02%
H:
0.0%
C:
0.0%
deal
sanofi
license
U.S. FDA Extends Review of Biologics License Application for REGEN-COV® (casirivimab and imdevimab) for Treatment and Prophylaxis of COVID-19
Published:
2022-04-14
(Crawled : 12:00)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-15.54%
|
O:
3.34%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-19.35%
|
O:
-1.56%
H:
0.0%
C:
0.0%
REGN
|
$896.27
0.26%
0.25%
500K
|
Health Technology
|
23.13%
|
O:
0.05%
H:
0.92%
C:
0.11%
covid-19
cov
treatment
fda
application
license
review
ABL Bio Enters Global Collaboration and License Agreement with SANOFI to Advance ABL301 for the Treatment of Parkinson's Disease
Published:
2022-01-11
(Crawled : 01:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-7.15%
|
O:
2.11%
H:
2.91%
C:
2.91%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-10.66%
|
O:
0.9%
H:
0.0%
C:
0.0%
treatment
license
disease
Ligand and GSK Expand Global Collaboration and License Agreement
Published:
2021-12-21
(Crawled : 22:00)
- biospace.com/
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-7.07%
|
O:
0.76%
H:
0.67%
C:
0.45%
LGND
|
$72.59
0.1%
0.1%
140K
|
Health Technology
|
-48.52%
|
O:
-0.12%
H:
0.06%
C:
-1.31%
license
collaboration
Baidu Enters Into License Agreement With Sanofi to Enable Next-Generation mRNA Therapeutics and Vaccines
Published:
2021-11-22
(Crawled : 13:30)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-8.6%
|
O:
-0.92%
H:
0.0%
C:
-0.23%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-9.65%
|
O:
-0.89%
H:
0.0%
C:
0.0%
BIDU
|
$95.025
-0.58%
-0.58%
1.8M
|
Technology Services
|
-37.84%
|
O:
-1.31%
H:
0.0%
C:
0.0%
vaccine
license
therapeutics
2021 Worldwide Pharma, Biotech & Diagnostics Industry Report - Leading Licensing Deals by Value Since 2015
Published:
2021-11-10
(Crawled : 12:15)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-9.84%
|
O:
-0.54%
H:
0.0%
C:
-0.01%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-11.56%
|
O:
0.66%
H:
0.25%
C:
-0.89%
biotech
iot
diagnostics
license
diagnostic
pharma
Pfizer and BioNTech Initiate Rolling Submission of Supplemental Biologics License Application to U.S. FDA for Booster Dose of COMIRNATY® in Individuals 16 and Older
Published:
2021-08-25
(Crawled : 17:00)
- globenewswire.com
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-47.46%
|
O:
-0.7%
H:
0.5%
C:
-1.1%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-12.67%
|
O:
-0.71%
H:
0.37%
C:
0.08%
BNTX
|
$86.82
0.75%
0.75%
1.6M
|
Health Technology
|
-76.6%
|
O:
-2.02%
H:
4.37%
C:
4.23%
fda
license
submission
comirnaty®
order
← Previous
1
2
Next →
Gainers vs Losers
67%
33%
Top 10 Gainers
AGBA
|
News
|
$1.26
215.0%
68.25%
130M
|
Finance
EGOX
|
$0.0515
43.06%
30.1%
330M
|
OLB
4
|
$0.33
-14.95%
25.53%
840K
|
Technology Services
NVFY
|
$2.77
31.28%
23.83%
33M
|
Consumer Durables
ZCMD
|
$1.87
28.97%
22.46%
31M
|
Commercial Services
RCON
|
$0.1112
13.01%
21.28%
1.7M
|
Distribution Services
INSG
|
$3.03
25.21%
20.13%
330K
|
Electronic Technology
GCTK
|
$0.8191
22.25%
18.2%
190K
|
Manufacturing
WLGS
|
$0.59
18.0%
17.9%
2.3M
|
ASNS
|
$0.828
21.75%
17.86%
18K
|
Your saved searches
Save your searches and get alerts when important news are released.